Video Experimental Relacionado
Updated: Jul 26, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Análisis de la decisión y directrices para la terapia anticoagulante para prevenir el accidente cerebrovascular en
R Thomson1, D Parkin, M Eccles
1Department of Epidemiology and Public Health, School of Health Sciences, Newcastle Medical School, Newcastle Upon Tyne, UK. richard.thomson@ncl.ac.uk
Lancet (London, England)
|April 18, 2000
Resumen
La terapia con warfarina para la fibrilación auricular no valvular puede prevenir el accidente cerebrovascular, reducir los costos de atención médica y mejorar la calidad de vida. El análisis de la decisión ayuda a crear directrices para el tratamiento anticoagulante, teniendo en cuenta las preferencias del paciente y la eficacia.
Área de la Ciencia:
- Medicina Cardiovascular La medicina cardiovascular es una especialidad de la salud.
- Economía de la salud Economía de la salud
- Ciencia de la decisión Ciencia de la decisión
Sus antecedentes:
- Faltan directrices clínicas para el tratamiento con anticoagulantes en la fibrilación auricular no valvular (FANV) para prevenir el accidente cerebrovascular.
- La warfarina es un anticoagulante común utilizado en pacientes con NVAF.
Objetivo del estudio:
- Para modelar la toma de decisiones para el tratamiento con warfarina en pacientes con fibrilación auricular (FA) utilizando el análisis de decisión de Markov.
- Desarrollar directrices basadas en la evidencia para la terapia anticoagulante en AF.
Principales métodos:
- Revisión sistemática de la literatura, estimaciones de la calidad de vida de los pacientes, análisis de datos del registro de accidentes cerebrovasculares y estimación de costos.
- Análisis de decisión de Markov que incorpora análisis de sensibilidad.
- Aplicación de directrices derivadas a una cohorte de pacientes con AF.
Principales resultados:
- El tratamiento con warfarina generalmente disminuyó los costos de atención médica y aumentó la calidad de vida en la mayoría de las combinaciones de riesgo.
- Las recomendaciones de tratamiento variaron significativamente según la edad, el sexo y las preferencias del paciente.
- El análisis de sensibilidad mostró que las decisiones de tratamiento dependían en gran medida de las estimaciones de la efectividad de la warfarina y el impacto en la calidad de vida.
Conclusiones:
- El análisis de decisiones integra efectivamente datos complejos para la toma de decisiones informadas en la terapia anticoagulante.
- Identificaron factores clave que influyen en las decisiones de tratamiento, incluidas las preferencias del paciente y la efectividad del medicamento.
- El estudio proporciona un marco para el desarrollo de directrices de evaluación para la prevención del ACV en la FA.
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...